The MRC’s internal Proximity to Discovery: Industry Engagement Fund (PtD) will aim to support individual mobility to enable early engagement with industry as well as placement opportunities with businesses that could accelerate the translational potential of your work. Work must be biomedically relevant and support the MRC’s remit.
The University will deliver PtD through two main schemes: Continue reading
On 12th May, the University of Birmingham is holding its second Translational Funding Event. We have had confirmation that representatives from BBSRC, CRUK, EPSRC, MRC and Wellcome Trust will attend and each give a brief presentation on how to submit a successful application to their translational funding schemes. We also hope to welcome ARUK, LLR and NIHR. There will be an informal networking lunch, and the opportunity to book a 1-2-1 slot (10-15 mins) to discuss your research and the suitability of it to a particular funder. Continue reading
UoB recently secured funding from the MRC’s new Proximity to Discovery: Industry Engagement Fund (PtD). This fund will aim to support individual mobility to enable early engagement with industry as well as placement opportunities with businesses that could accelerate the translational potential of your work. Work must be biomedically relevant and support the MRC’s remit.
The University will deliver PtD through 2 main schemes: Continue reading
I hope everybody enjoyed relaxing Christmas breaks, and came back full of newfound enthusiasm as we hit the ground running in the New Year. Whether you’re wondering what the results of the REF mean (there are some excellent – albeit slightly gloomy! – articles in Research Fortnight here); thinking about new funding schemes available from the Wellcome Trust (with more to come in the next few months, according to their 2014 annual report) and others such as the MRC’s new Industry Asset Sharing Initiative or pondering the broader underpinning messages of the Government’s new Science & Innovation Strategy (a nice quick overview from the Society of Biology here and a good blog post through LSE here); there is clearly plenty to be thinking about. Continue reading
The R&KT Office is holding its first seminar of the academic year TOMORROW, Thursday 2nd October, between 1-2 pm in the IBR Seminar Room (N143).
The seminar will highlight the information we produce in the R&KT Office about funding opportunities and some of the more unusual opportunities.
Please come along if you can! Continue reading
Would you like to sit on a board or panel for the MRC?
The Research Boards hold their own research budgets and review and manage scientific activity within their specialist areas.
Applications are now being invited from scientists with the relevant experience and expertise to become members of Boards and Panels from April 2015. There are 22-25 vacancies in the four Research Boards, and 22 vacancies in the MRC’s six Panels.
Further information is available on the MRC website.
The Medical Research Council (MRC) in the UK and the Department of Biotechnology (DBT) in India in collaboration with Department of International Development (DFID) are pleased to announce a joint call to fund Global Health Research which will bring together researchers from the UK, India and Low Income Countries.
The purpose of this call is to fund Global Health Research projects which will bring together researchers from the UK, India and low income countries. It aims to fund work which addresses health needs of the most disadvantaged populations globally. The scope of the call is research proposals that address major health needs of women and children in low resource settings. Continue reading
MRC launches institutional Confidence in Concept and Proximity to Discovery: Industry Engagement Fund
The MRC recently announced that the 2014 call for institutional applications to the Confidence in Concept scheme is live. Running alongside this, the MRC has launched a second institutional pilot scheme, Proximity to Discovery: Industry Engagement Fund, which will provide awards to institutions to be used flexibly to support the development of relationships with industry partners. Funding will enable research organisations to be proactive in developing collaboration and allow a greater flexibility to respond quickly to opportunities as they arise. Short term people exchanges between industry and academia are considered a key component. Continue reading
Business Secretary Vince Cable recently announced a new scheme to grant UK researchers access to a range of valuable deprioritised pharmaceutical compounds.
This is being led by the Medical Research Council in partnership with seven global pharmaceutical companies: AstraZeneca, GlaxoSmithKline, Janssen Research & Development LLC, Lilly, Pfizer, Takeda and UCB.
This will allow researchers to conduct new studies to improve our understanding of disease, which could in turn lead to more effective treatments.
The compounds have all undergone some industry development but were not effective enough against the target disease. However, they could be used to fight other diseases with similar pathways.
For more information please see the original article.
In June, the Prime Minister announced the creation of the UK Dementias Research Platform, which will be the world’s largest study group for dementia research.
This £16 million programme (including £4 million industry partnership funding) has been developed and will be led by the Medical Research Council. It aims to accelerate progress in dementia research, in particular research into the early detection, improved treatment and prevention of the condition. Two million people are available to take part.